What To Know
- Certainly, this long-term agreement is not only limited to the cooperation for the next five years but also contains a long-term availability of spare parts beyond the terms of this agreement in order to provide the best service to our customers.
- Hoya notes EUS consists of a diagnostic ultrasound system and ultrasound flexible endoscopes and is used for examinations to evaluate the cancer staging in the liver, pancreas, and bronchus.
March 29 2021
Hoya notes EUS consists of a diagnostic ultrasound system and ultrasound flexible endoscopes and is used for examinations to evaluate the cancer staging in the liver, pancreas, and bronchus.
PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions. Details can be confirmed in the joint press release on July 6, 2020, here.
Hitachi concluded an absorption-type company split agreement regarding the transfer of its diagnostic imaging-related business (CT, MRI, X-ray Systems, Ultrasound, and electronic health records) to FUJIFILM Corporation, and has announced to set the closing date of share transfer, which had not yet been decided, to March 31, 2021, and this agreement will be valid after such transfer.
Certainly, this long-term agreement is not only limited to the cooperation for the next five years but also contains a long-term availability of spare parts beyond the terms of this agreement in order to provide the best service to our customers.
Gerald Bottero, Global President of PENTAX Medical, HOYA Corporation, stated, “We are honored to continue our alliance with Hitachi which began with joint research in 1983 leading to the first commercial launch of our EUS in 1990. The Hitachi ultrasound technology is globally recognized as an important standard in EUS with high-quality imaging, advanced software modalities, and ease of use. We look forward to working with Hitachi’s world-class research teams to accelerate innovation and wide adoption in this vital space.”